Antibiotic content of selective culture media for isolation of Capnocytophaga species from oral polymicrobial samples, Lett Appl Microbiol, vol.57, pp.303-312, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00933778
High prevalence of ??-lactam and macrolide resistance genes in human oral Capnocytophaga species, Journal of Antimicrobial Chemotherapy, vol.69, issue.2, pp.381-385, 2014. ,
DOI : 10.1093/jac/dkt350
URL : https://hal.archives-ouvertes.fr/inserm-00925039
Species in Patients with Neutropenia and Cancer: Results of a Multicenter Study, Clinical Infectious Diseases, vol.33, issue.4, pp.20-22, 2001. ,
DOI : 10.1086/322649
Brain Abscess Associated with Multidrug-Resistant Capnocytophaga ochracea Infection, Journal of Clinical Microbiology, vol.45, issue.2, pp.645-652, 2007. ,
DOI : 10.1128/JCM.01815-06
Multidrug-resistant oral Capnocytophaga gingivalis responsible for an acute exacerbation of chronic obstructive pulmonary disease: Case report and literature review, Anaerobe, vol.42, pp.50-54, 2016. ,
DOI : 10.1016/j.anaerobe.2016.08.003
URL : https://hal.archives-ouvertes.fr/hal-01372447
Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period, BMC Infect Dis, vol.9, p.32, 2005. ,
Genetic Analysis of an Ambler Class A Extended-Spectrum Beta-Lactamase from Capnocytophaga ochracea, Journal of Clinical Microbiology, vol.42, issue.2, pp.888-90, 2004. ,
DOI : 10.1128/JCM.42.2.888-890.2004
Bacteremia by multidrug-resistant Capnocytophaga sputigena, J Clin Microbiol, vol.32, pp.1067-1076, 1994. ,
Pneumonia and sepsis due to fluoroquinolone-resistant Capnocytophaga gingivalis after autologous stem cell transplantation, Bone Marrow Transplantation, vol.28, issue.12, pp.1171-1174, 2001. ,
DOI : 10.1038/sj.bmt.1703288
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates, Journal of Antimicrobial Chemotherapy, vol.44, issue.6, pp.735-777, 1999. ,
DOI : 10.1093/jac/44.6.735
Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates, International Journal of Antimicrobial Agents, vol.35, issue.1, pp.76-85, 2010. ,
DOI : 10.1016/j.ijantimicag.2009.08.003
Role of Topoisomerase Mutations and Efflux in Fluoroquinolone Resistance of Bacteroides fragilis Clinical Isolates and Laboratory Mutants, Antimicrobial Agents and Chemotherapy, vol.48, issue.4, pp.1344-1350, 2004. ,
DOI : 10.1128/AAC.48.4.1344-1346.2004
Roles of gyrA Mutations in Resistance of Clinical Isolates and In Vitro Mutants of Bacteroides fragilis to the New Fluoroquinolone Trovafloxacin, Antimicrobial Agents and Chemotherapy, vol.44, issue.7, pp.1842-1847, 2000. ,
DOI : 10.1128/AAC.44.7.1842-1845.2000
Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli, Antimicrob Agents Chemother, vol.43, pp.868-75, 1999. ,
Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones, Clinical Infectious Diseases, vol.32, issue.Supplement 1, pp.9-15, 2001. ,
DOI : 10.1086/319370
Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis, Journal of Antimicrobial Chemotherapy, vol.66, issue.3, pp.476-86, 2011. ,
DOI : 10.1093/jac/dkq485
Plasmid-mediated quinolone resistance determinants in quinolone-resistant Escherichia coli isolated from patients with bacteremia in a university hospital in Taiwan, 2001???2015, Scientific Reports, vol.63, issue.1, p.32281, 2001. ,
DOI : 10.1016/j.mimet.2005.03.018
Prevalence and characterization of plasmid-mediated quinolone resistance genes in Aeromonas spp. isolated from South African freshwater fish, International Journal of Food Microbiology, vol.231, pp.26-32, 2016. ,
DOI : 10.1016/j.ijfoodmicro.2016.04.030